Back to the full story11 sources · Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer◆ Analytics
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
Deterministic text analytics computed across all 11 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
cancervaccinemodernamrnamelanomamercktrialtreatmentskinexperimental
Top phrases
moderna and merckcancer vaccineskin cancermelanoma vaccinemrna cancermrna cancer vaccinemrna vaccineexperimental melanoma vaccinemoderna and merck sharesexperimental melanoma
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
- Moderna · 9 sources
- Merck · 8 sources
- Keytruda · 4 sources
- Jon LaPook · 2 sources
- Merck's · 2 sources
- People · 2 sources
Unique to one source
- Drug · CBS News — Top
- Janice Mehnert · CBS News — Top
- STAT · STAT
- Between · STAT
- Twenty · STAT
- How Moderna's · CBS News
- CBS News · CBS News
- Gounder · CBS News
- Nature · Nature
- Published · Nature
- Promising · Nature
- Cancer · CNBC
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "People given the experimental vaccine with standard treatment lived longer without their cancer returning, the companies reported this week." · Gizmodo
- "Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors." · PBS NewsHour
- "Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients." · CBS News — Top
- "Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies." · STAT
- "Twenty-four hours later, my brain is still whirling over yesterday’s stunning news from Merck and Moderna about the success of their personalized mRNA cancer therapy in a melanoma late-stage clinical trial." · STAT
- "Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer." CBS News medical correspondent Dr." · CBS News
- "Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer."" · CBS News
- "Nature, Published online: 20 August 2026; doi:10.1038/d41586-026-02612-3 Promising trial results suggest cancer vaccines work and could be used to target other tumours." · Nature